Throughout the nearly 30-year history of downtown Winston-Salem s life-sciences hub, the cliché that the "only constant is change" is not only applicable, but an embraced mantra.
Mr. Cullison brings over 20 years of experience in the pharmaceutical industry with a broad range of expertise across business development and strategic planningFRAMINGHAM, MA / ACCESSWIRE / May 3, 2023
Stock Analysts’ updated eps estimates for Wednesday, June 1st: Arcos Dorados (NYSE:ARCO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Arcos Dorados Holdings Inc. operates as a franchisee of McDonald’s with its operations divided in Brazil; North Latin America division; South Latin America and […]
Catalyst Biosciences (NASDAQ:CBIO – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, Zacks.com reports. The brokerage presently has a $1.50 price target on the biopharmaceutical company’s stock. Zacks Investment Research‘s target price suggests a potential upside of 26.05% […]